Nicolas Saglio

kennek makes lenders lives easier. More than just a loan management system. Our mission is to revolutionise the private debt market through data & technology. kennek helps lenders operate efficiently and scale easily, providing the best-in-class technology to manage everything from Loan Origination, to Servicing & Monitoring, as well as Portfolio management and Investor Reporting. All without the need to develop anything in-house so lenders can simply focus on their origination channels.

Abi Global Health delivers telemedicine solutions in 37 countries across 6 continents. Our unique artificial intelligence and machine learning technology enables our network of over 1,000 healthcare professionals to provide quick answers to users in 24 languages across a choice of interfaces.

30 TECHNOLOGY is developing and defining new models of care to treat many serious medical conditions by enhancing the body's healing and defence mechanisms.

kennek makes lenders lives easier. More than just a loan management system. Our mission is to revolutionise the private debt market through data & technology. kennek helps lenders operate efficiently and scale easily, providing the best-in-class technology to manage everything from Loan Origination, to Servicing & Monitoring, as well as Portfolio management and Investor Reporting. All without the need to develop anything in-house so lenders can simply focus on their origination channels.

Exostatics Pharmaceuticals S.L. is a biotech company, spin-off from the University of Bordeaux (France). The company has developed a patented technology based on synthetic chemosensors for the efficient isolation of exosomes and other circulating microvesicles from biological fluids (urine, plasma, etc.) for use in the diagnosis and prognosis of diseases. The patented compound has been validated in a proof of concept with urine and plasma samples for the detection of nephropathies, obtaining promising results in the uptake of these extracellular vesicles. By not targeting a specific biomarker and with a simpler laboratory process which preserves the integrity of exosomes, we provide a broader set of applications both for diagnostic and therapeutic purposes, across multiple health conditions.

Abi Global Health delivers telemedicine solutions in 37 countries across 6 continents. Our unique artificial intelligence and machine learning technology enables our network of over 1,000 healthcare professionals to provide quick answers to users in 24 languages across a choice of interfaces.

Hemostatics is developing a novel antifibrinolytic agent to reduce bleeding in life-threatening and disabling haemorrhagic conditions. Thanks to an innovative mechanism of action to inhibit fibrinolysis, our patented preclinical candidate is aiming to address a number of significant unmet medical needs in trauma, surgery, ICH, PPH, GI bleeding and in several bleeding disorders (Rare Diseases).

SkyPath Capital Partners is an innovation focused strategy advisory firm and private investment boutique focused on funding for technology and technology enabled industries